miR in CLL: more than mere markers of prognosis?

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

In this issue of Blood, Mraz et al show that microRNA-150 (miR-150) is the most abundantly expressed miR in chronic lymphocytic leukemia (CLL) and affects the threshold for B-cell receptor (BCR) signaling by repressing expression levels of GAB1 and FOXP1. This functional link might explain the described association between expression levels of miR-150 and prognosis.(1)
Original languageEnglish
Pages (from-to)2-4
JournalBlood
Volume124
Issue number1
DOIs
Publication statusPublished - 2014

Cite this